Bernstein Initiates Coverage On Guardant Health with Outperform Rating, Announces Price Target of $34
Portfolio Pulse from Benzinga Newsdesk
Bernstein analyst Eve Burstein has initiated coverage on Guardant Health (NASDAQ:GH) with an Outperform rating and a price target of $34.

September 28, 2023 | 10:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health has been given an Outperform rating and a price target of $34 by Bernstein analyst Eve Burstein.
The Outperform rating from Bernstein indicates a positive outlook for Guardant Health. The price target of $34 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor interest and a potential rise in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100